Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC) Meeting Abstract


Authors: Khasraw, M.; Mukaro, V. R.; West, L.; Brandt, C.; Woollett, A. M.; Edwards, M.; Spokes, R.; Mitchell, G.; Prince, K.; Hayes, T. M.; Collins, I. M.; Guminski, A. D.; Baron-Hay, S. E.; Olesen, I. H.; Bryan, J.; Bowles, S.; Wong, S. F.; Ashley, D. M.; Patil, S.
Abstract Title: Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC)
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036902249
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.e12025
Notes: Meeting Abstract: e12025 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil